Using synthetic lethal based approach to predict drug and biomarker pairs for personalized medicine
碩士 === 國立陽明大學 === 生物藥學研究所 === 104 === Recently, synthetic lethality (SL) has emerged as a novel anti-cancer strategy. SL is a type of genetic interaction between two genes such that simultaneous perturbations of two genes result in cell death or a dramatic decrease in cell viability, while a perturb...
Main Authors: | Nai-Chia Yu, 游乃嘉 |
---|---|
Other Authors: | Chi-Ying F. Huang |
Format: | Others |
Language: | en_US |
Published: |
2016
|
Online Access: | http://ndltd.ncl.edu.tw/handle/67148904774180717372 |
Similar Items
-
Using synthetic lethality to predict therapeutic biomarkers for drug repositioning and drug discovery
by: Kun-Lin Chuang, et al.
Published: (2018) -
Predictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized Medicine
by: Stephen Murata, et al.
Published: (2016-01-01) -
An in-silico approach to predict and exploit synthetic lethality in cancer metabolism
by: Iñigo Apaolaza, et al.
Published: (2017-09-01) -
Harnessing synthetic lethality to predict the response to cancer treatment
by: Joo Sang Lee, et al.
Published: (2018-06-01) -
Synthetic lethality guiding selection of drug combinations in ovarian cancer.
by: Andreas Heinzel, et al.
Published: (2019-01-01)